Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2018 Dec 4;169(11):751-760.
doi: 10.7326/M18-0670. Epub 2018 Nov 6.

Use of High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia: A Cohort Study

Muhammad Hammadah  1 , Jeong Hwan Kim  1 , Ayman Samman Tahhan  1 , Bryan Kindya  1 , Chang Liu  1 , Yi-An Ko  2 , Ibhar Al Mheid  1 , Kobina Wilmot  1 , Ronnie Ramadan  1 , Ayman Alkhoder  1 , Fahad Choudhary  1 , Mohamad Mazen Gafeer  1 , Naser Abdelhadi  1 , Pratik Pimple  2 , Pratik Sandesara  1 , Bruno B Lima  1 , Amit J Shah  3 , Laura Ward  2 , Michael Kutner  2 , J Douglas Bremner  1 , David S Sheps  4 , Paolo Raggi  5 , Laurence S Sperling  1 , Viola Vaccarino  3 , Arshed A Quyyumi  1
Affiliations
Observational Study

Use of High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia: A Cohort Study

Muhammad Hammadah et al. Ann Intern Med. .

Abstract

Background: Many patients with coronary artery disease (CAD) are routinely referred for surveillance stress testing despite recommendations against it.

Objective: To determine whether low levels of resting high-sensitivity cardiac troponin I (hs-cTnI) can identify persons without inducible myocardial ischemia.

Design: Observational study.

Setting: A university-affiliated hospital network.

Patients: Persons with stable CAD: 589 in the derivation group and 118 in the validation cohort.

Measurements: Presence of inducible myocardial ischemia was determined by myocardial perfusion imaging with technetium-99m single-photon emission computed tomography during either treadmill or pharmacologic stress testing. Resting plasma hs-cTnI was measured within 1 week of the stress test, and the negative predictive value (NPV) for inducible ischemia was calculated. The derivation cohort was followed for 3 years for incident cardiovascular death and myocardial infarction.

Results: In the derivation cohort, 10 of 101 patients with an hs-cTnI level below 2.5 pg/mL had inducible myocardial ischemia (NPV, 90% [95% CI, 83% to 95%]) and 3 of 101 had inducible ischemia involving at least 10% of the myocardium (NPV, 97% [CI, 92% to 99%]). In the validation cohort, 4 of 32 patients with an hs-cTnI level below 2.5 pg/mL had inducible ischemia (NPV, 88% [CI, 71% to 96%]) and 2 of 32 had ischemia of 10% or greater (NPV, 94% [CI, 79% to 99%]). After a median follow-up of 3 years in the derivation cohort, no adverse events occurred in patients with an hs-cTnI level below 2.5 pg/mL, compared with 33 (7%) cardiovascular deaths or incident myocardial infarctions among those with an hs-cTnI level of 2.5 pg/mL or greater.

Limitation: The data may not be applicable to a population without known CAD or to persons with unstable angina, and the modest sample sizes warrant further validation in a larger cohort.

Conclusion: Very low hs-cTnI levels may be useful in excluding inducible myocardial ischemia in patients with stable CAD.

Primary funding source: National Institutes of Health.

PubMed Disclaimer

Conflict of interest statement

Disclosures: Dr. Al Mheid reports grants from NIH during the conduct of the study. Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-0670.

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Rozanski A, Gransar H, Hayes SW, Min J, Friedman JD, Thomson LE, et al. Temporal trends in the frequency of inducible myocardial ischemia during cardiac stress testing: 1991 to 2009. J Am Coll Cardiol. 2013;61:1054–65. doi:10.1016/j.jacc.2012.11.056 - DOI - PubMed
    1. Ladapo JA, Blecker S, Douglas PS. Physician decision making and trends in the use of cardiac stress testing in the United States: an analysis of repeated cross-sectional data. Ann Intern Med. 2014;161: 482–90. doi:10.7326/M14-0296 - DOI - PMC - PubMed
    1. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al.; American College of Cardiology Foundation/American Heart Association Task Force. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2012;126:e354–471. doi:10.1161/CIR.0b013e318277d6a0 - DOI - PubMed
    1. Shah BR, Cowper PA, O’Brien SM, Jensen N, Drawz M, Patel MR, et al. Patterns of cardiac stress testing after revascularization in community practice. J Am Coll Cardiol. 2010;56:1328–34. doi:10.1016/j.jacc.2010.03.093 - DOI - PubMed
    1. Bradley SM, Hess E, Winchester DE, Sussman JB, Aggarwal V, Maddox TM, et al. Stress testing after percutaneous coronary intervention in the Veterans Affairs healthcare system: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. Circ Cardiovasc Qual Outcomes. 2015;8:486–92. doi:10.1161/CIRCOUTCOMES.114.001561 - DOI - PubMed

Publication types